% Expired Patents = 25.0

EPO Patents = 2

Forward Citations = 21

Loading Chart...

4 inventors (with patents filed for the assignee):

David Weinstein (3 out of 6 patents)

Linda Shawn Higgins (1 out of 38 patents)

Kathleen M Lee (1 out of 15 patents)

4. Dennis Lanfear (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 9867816 - PPARγ agonists for treatment of multiple sclerosis (2018-01-16),

2. 9675603 - Solid pharmaceutical compositions of ppary modulator (2017-06-13),

3. 9539249 - PPAR gamma agonists for treatment of multiple sclerosis (2017-01-10),

4. 9061020 - PPAR gamma agonists for treatment of multiple sclerosis (2015-06-23),

Company Overview

Intekrin Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for metabolic diseases. With a focus on diabetes and obesity, Intekrin is committed to improving patient outcomes through its cutting-edge research and development efforts. By targeting key pathways in metabolism, Intekrin aims to revolutionize the treatment of these widespread health issues.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#247 in Redwood City, CA

#14,041 in California

#60,597 in US

Redwood City, CA, United States of America

Intekrin Therapeutics, Inc.

Forward Citations = 21

4 inventors:

David Weinstein (3 out of 6 patents)

Linda Shawn Higgins (1 out of 38 patents)

Kathleen M Lee (1 out of 15 patents)

4. Dennis Lanfear (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intekrin Therapeutics, Inc.. Retrieved from https://idiyas.com/company/intekrin-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]